Skip to content

Study · Observational study · n = 6 · 1989

1 result

Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonists (goserelin)--lack of shrinkage of uterine fibroids.

Lumsden MA, West CP, Hillier H, Baird DT

Fertility and sterility1 Dec 1989Cited by 21 (Europe PMC)

PMID2531684 (opens in a new tab)DOI10.1016/s0015-0282(16)53153-7 (opens in a new tab)PepBankPUB-02531684
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanObservational studyActivity measurement

    In women with uterine fibroids receiving goserelin alone, FSH remained within the pretreatment range.

    In plain wordsIn women with uterine fibroids receiving goserelin alone, FSH remained within the pretreatment range.

    Peptide
    Goserelin
    Outcome
    Direction not reportedFollicle stimulating hormone
    Study

    n = 6

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    in contrast with results during goserelin alone when FSH levels remained within the pretreatment range.
    1 context sentence
    Summary · context
    Results were compared with those from six women, matched for pretreatment uterine volume, who had been treated with goserelin alone.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.